Vanguard Global Advisers »

Kyverna Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $129k 15k 8.63

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Kyverna Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
AIGH Capital Management
Deerfield Management Company
Vanguard Capital Management
Vanguard Group
Adage Capital Partners GP
Balyasny Asset Management
Millennium Management
Insight Holdings
Morgan Stanley
BlackRock
Woodline Partners
D. E. Shaw & Co
Propel Bio Management

View all funds holding Kyverna Therapeutics